15 November 2023
15 November 2023
AI and its responsible use took centre stage at the 2023 National Institute for Health and Care Excellence (NICE) Conference in Manchester on 7 November
Atreca has made significant cuts to its workforce for the second consecutive quarter in 2023.
The trial enrolled 328 subjects at 88 trial sites across more than countries.
The Massachusetts-based company has said that zilebesiran significantly reduced blood pressure in patients living with hypertension.
The company intends to use the funds to advance its cancer vaccine clinical pipeline, including a colorectal cancer vaccine.
Under the deal, ObvioHealth has the option to use the Instand Consult telehealth services of Chemist Warehouse.
The trial expansion will help increase options and access to experimental therapies for Australians diagnosed with GBM.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
